These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2867823)

  • 1. A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome.
    Fujita J; Seino Y; Ishida H; Taminato T; Matsukura S; Horio T; Imamura S; Naito A; Tobe T; Takahashi K
    Cancer; 1986 Feb; 57(4):860-5. PubMed ID: 2867823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case with glucagonoma syndrome--endocrine and metabolic studies.
    Fukushima H; Yamaguchi K; Uzawa H; Kitoh M; Takemiya M; Konno T
    Endocrinol Jpn; 1981 Apr; 28(2):111-25. PubMed ID: 6273136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic studies and glucagon gel filtration pattern before and after surgery in a case of glucagonoma syndrome.
    von Schenck H; Thorell JI; Berg J; Bojs G; Dymling JF; Hallengren B; Ljungberg O; Tibblin S
    Acta Med Scand; 1979; 205(3):155-62. PubMed ID: 218426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
    Tanaka K; Watabe T; Shimizu N; Horiuchi T; Nakamura K; Yoshida H
    Metabolism; 1984 Aug; 33(8):728-33. PubMed ID: 6087085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
    Hendriks T; Jansen JB; van Tongeren JH
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The glucagonomas (author's transl)].
    Luyckx AS; Lefebvre PJ
    Diabete Metab; 1981 Dec; 7(4):289-300. PubMed ID: 6120860
    [No Abstract]   [Full Text] [Related]  

  • 7. Malignant glucagonoma syndrome: response to chemotherapy.
    Marynick SP; Fagadau WR; Duncan LA
    Ann Intern Med; 1980 Sep; 93(3):453-4. PubMed ID: 6254416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
    Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
    Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and metabolic aspects of glucagonoma.
    Leichter SB
    Medicine (Baltimore); 1980 Mar; 59(2):100-13. PubMed ID: 6987481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
    Moattari AR; Cho K; Vinik AI
    Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic insulinoma with long survival and glucagonoma syndrome.
    D'Arcangues CM; Awoke S; Lawrence GD
    Ann Intern Med; 1984 Feb; 100(2):233-5. PubMed ID: 6318634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
    Torre L; Vazquez JA; Blázquez E
    Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo studies on glucagonoma tissue.
    Berger M; Teuscher A; Halban P; Trimble E; Studer PP; Wollheim CB; Zimmermann-Telschow H; Muller WA
    Horm Metab Res; 1980 Apr; 12(4):144-50. PubMed ID: 6104627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethyltriazenoimidazole carboxamide therapy of islet cell carcinoma of the pancreas.
    Awrich AE; Peetz M; Fletcher WS
    J Surg Oncol; 1981; 17(4):321-6. PubMed ID: 6267376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operative and chemotherapeutic management of malignant glucagon-producing tumors.
    Prinz RA; Badrinath K; Banerji M; Sparagana M; Dorsch TR; Lawrence AM
    Surgery; 1981 Oct; 90(4):713-9. PubMed ID: 6269242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
    Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
    Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration.
    Santangelo WC; Unger RH; Orci L; Dueno MI; Popma JJ; Krejs GJ
    Pancreas; 1986; 1(5):464-9. PubMed ID: 2882503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A familial glucagonoma syndrome: genetic, clinical and biochemical features.
    Stacpoole PW; Jaspan J; Kasselberg AG; Halter SA; Polonsky K; Gluck FW; Liljenquist JE; Rabin D
    Am J Med; 1981 May; 70(5):1017-26. PubMed ID: 6112877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effects of somatostatin analog (SMS 201-995) on pancreatic hormones in patients with malignant islet-cell carcinoma].
    Fukushima H; Ueno S; Sakakida M; Takahashi T; Shirotani T; Araki E; Kishikawa H; Yamaguchi K; Nakamura N; Uzawa H
    Nihon Naibunpi Gakkai Zasshi; 1988 Aug; 64(8):666-76. PubMed ID: 2852126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
    Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
    Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.